Events Calendar
EGDRC Virtual Seminar | Insulin Access and Health Outcomes After the Inflation Reduction Act’s Out-of-Pocket Spending Caps
Monday, November 17 12:00pm-1:00 PM EST
In this talk, Dr. Rebecca Myerson, Associate Professor of Health Policy & Management at the Rollins School of Public Health, explores how the Inflation Reduction Act’s $35 cap on out-of-pocket insulin costs for Medicare beneficiaries is influencing medication access and health outcomes. Drawing on her award-winning research into how public policy and information interventions impact health care access and insurance uptake, Dr. Myerson will offer empirical insights that help shape strategies for improving access not only to insulin but potentially other life-saving medications.
About the Speaker
Rebecca Myerson is an Associate Professor in the Department of Health Policy and Management at
Emory’s Rollins School of Public Health, who recently joined Emory in August. Her research examines
the impacts of public policies and information interventions on take-up of insurance coverage, health
care access, and health outcomes. She holds a doctorate in public policy from the University of Chicago
and a master in public health from the University of Washington.
